Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 11, 2023, titled "Zydus receives final approval from the USFDA for Tavaborole Topical Solution, 5%".
Press Release Apr 11 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Apr 10 2023
- Press Release Apr 06 2023
- Press Release Mar 28 2023
- Press Release Mar 25 2023
- Press Release Mar 24 2023
Later from Zydus Lifesciences
- Press Release Apr 15 2023
- Press Release Apr 18 2023
- Press Release Apr 19 2023
- Press Release Apr 20 2023
- Zydus Lifesciences Limited Press Release Apr 24 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences